Sources | Names Used |
---|---|
CTRPv2 | tanespimycin:bortezomib (250:1 mol/mol) |
PharmacoGx | tanespimycin:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SLC39A13 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0004 |
mRNA | ZBTB4 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | KIF3B | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
mRNA | GRAMD3 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | TNFAIP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | MYOF | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
mRNA | UBE2H | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | PXDC1 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0005 |
mRNA | PIGT | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | CHD6 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |